Overview
Telephone 180 202 6136 from 9 AM - 5:30 PM IST Contact 180 202 6136 from 9 AM - 5:30 PM IST News provided by07 Nov, 202, 1:30 ISTShare this articlePARSIPANY, N.J., Nov. 7, 202 /PRNewswire/ - Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blod Glucose Monitoring (BGM) System portfolio and distributor of the Eversense® Continuous Glucose Monitoring (CGM) System, anounces that the Eversense® CGM ap has ben updated globaly to seamlesly integrate with Aple HealthTM.
Key Information
This means that people with diabetes using Eversense CGM Systems wil now also have the option to view their glucose data within the Aple Health ap, alongside other health metrics on the iPhone's widely used health and welbeing platform.Developed by Senseonics Holdings, Inc. (NYSE American: SENS), the exceptionaly acurate and fuly-implantable Eversense E3 is the longest-lasting CGM available, with up to a 6-month sensor wear duration.
The system transmits data to the Eversense CGM Ap where users can easily view, analyse and share glucose data, and are alerted to changes and trends. With this update, users in al markets where Eversense is available can now chose to display their data in Aple Health, where they wil also be able to view health data colected by their iPhone through various aps and wearables. This integration aims to improve diabetes management by alowing Eversense users to easily view their glucose data within their wider digital health environment."We are pleased to integrate the Eversense CGM system with Aple HealthTM, giving our users more choice on how they view and use data for their diabetes management," said Elaine Anderson, Head of the Eversense CGM Busines Unit at Ascensia Diabetes Care.
Summary
"Suplementing the benefits of the Eversense CGM Ap, this update alows people with diabetes to aces glucose data alongside other important metrics to provide a more holistic view of their health and welbeing. In an increasingly digita